Inflammatory Bowel Disease Management
Authors:
- 1 February 1997
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 53 (2) , 189-194
Abstract
This article is intended to stimulate thought and focus on those areas where we feel advances in drug therapy for inflammatory bowel disease may occur. It is not an extensive review of current practice, although this is considered where it is thought to be pertinent to future developments. There are several excellent reviews of current practice which we do not attempt to repeat, nor do we give a comprehensive set of references, but cite well referenced reviews where necessary. New therapeutic developments should ideally stem from an understanding of the cause or pathogenesis of a condition; alternatively, established therapies may be modified or used as a basis for progress. Since the causes of both ulcerative colitis and Crohn’s disease remain unknown, most forward thinking on drug development must come from current practice, but remain open to novel approaches. Our thoughts on possible future treatments for inflammatory bowel disease are somewhat selective, and because of their speculative nature are unlikely to coincide with those of others — only the future will reveal genuine advances as they become incorporated into established practice.Keywords
This publication has 28 references indexed in Scilit:
- Inflammatory bowel disorders: current and future drugs that modulate adhesion molecules.1997
- A Comparison of Budesonide with Prednisolone for Active Crohn's DiseaseNew England Journal of Medicine, 1994
- Rolling review: inflammatory bowel diseasAlimentary Pharmacology & Therapeutics, 1993
- Comparison of bismuth citrate and 5-aminosalicylic acid enemas in distal ulcerative colitis: a controlled trial.Gut, 1993
- Release of drugs formulated as hard pastes filled into hard gelatin capsules. Part 1. Physical properties and in vitro testing.1984
- Studies of two novel sulfasalazine analogs, ipsalazide and balsalazideDigestive Diseases and Sciences, 1983
- Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis.Gut, 1982
- 5-Aminosalicylic Acid in a Slow-Release Preparation: Bioavailability, Plasma Level, and Excretion in HumansGastroenterology, 1982
- An oral preparation to release drugs in the human colon.British Journal of Clinical Pharmacology, 1982
- Non-smoking: a feature of ulcerative colitis.BMJ, 1982